Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Straumann Holding AGXSWX:STMN +1.07%96 Days Sales Outstanding is 82.45 as of Dec. 2025, which is 29% above its 10-year median of 63.98. GuruFocus rates XSWX:STMN with a GF Score™ of 96/100 and a GF Value™ of CHF137.92 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 61.04% on this metric.
The historical rank and industry rank for Straumann Holding AG's Days Sales Outstanding or its related term are showing as below:
XSWX:STMN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.12 Med: 63.98 Max: 73.93
Current: 73.85
During the past 13 years, Straumann Holding AG's highest Days Sales Outstanding was 73.93. The lowest was 54.12. And the median was 63.98.
XSWX:STMN's Days Sales Outstanding is ranked worse than 61.04% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 66.27
vs XSWX:STMN: 73.85
Straumann Holding AG's Days Sales Outstanding
increased
from Dec. 2024 (75.96) to Dec. 2025 (82.45).
Straumann Holding AG (XSWX:STMN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Straumann Holding AG Days Sales Outstanding Related Terms
Straumann Holding AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Days Sales Outstanding falls into.
Straumann Holding AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a Days Sales Outstanding of 82.45 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Straumann Holding AG and its competitors. This is 29% above median its historical median of 63.98. Over the past decade, Straumann Holding AG's Days Sales Outstanding has ranged from 54.12 to 73.93. According to the industry distribution chart, Straumann Holding AG ranks #495 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 61%.
Is Straumann Holding AG's Days Sales Outstanding too high?
Straumann Holding AG's current Days Sales Outstanding of 82.45 is 29% above median its 10-year median of 63.98. Over the past 10 years, this metric has ranged from a low of 54.12 to a high of 73.93. The Medical Devices & Instruments industry median Days Sales Outstanding is 66.27. Straumann Holding AG's value of 82.45 is 24.4% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #495 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Straumann Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #495 out of 811 companies for Days Sales Outstanding. This places Straumann Holding AG in the lower half of its industry. The industry median Days Sales Outstanding is 66.27. Straumann Holding AG's value of 82.45 is 24.4% above this benchmark. Historically, Straumann Holding AG's own Days Sales Outstanding has ranged from 54.12 to 73.93 over the past decade. While the company's 10-year median is 63.98 vs. the industry median of 66.27, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 66.27, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current Days Sales Outstanding of 82.45 is 24.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 66.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Days Sales Outstanding is 82.45, which is 29% above median its own 10-year median of 63.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF137.92, compared to a current price of CHF104.00 — trading 24.6% below its estimated fair value. The current Days Sales Outstanding is 82.45, which is 29% above median its 10-year median of 63.98 and 24.4% above the Medical Devices & Instruments industry median of 66.27. Straumann Holding AG's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Days Sales Outstanding is 82.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF104.00 is trading 24.6% below its estimated GF Value™ of CHF137.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Days Sales Outstanding: 82.45 (29% above median its 10-year median of 63.98)
GF Value™: CHF137.92 vs. price of CHF104.00 (24.6% below fair value)
Industry Position: 24.4% above the Medical Devices & Instruments median (#495 of 811)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
96GF Score
Get the complete analysis for XSWX:STMN
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
